Compounds derived from furo [3,2-d] pyrimidine and its salts； a Pharmaceutical composition that comprises； and its use to treat a condition that is mediated by the activity of a protein kinase, such as cancer, cardiovascular disorders, and CNS and Immune related diseases Institute Unodeficiencia learned.
The present invention is directed to novel compounds of Formula (I) pharmaceutically acceptable salts, biologically active metabolites, pro-drugs, racemates, enantiomers, diastereomers, solvates and hydrates thereof wherein the variables are defined as herein. The compounds of Formula (I) are useful as kinase inhibitors and as such would be useful in treating certain conditions and diseases, especially inflammatory conditions and diseases and proliferative disorders and conditions, for example, cancers.COMPUESTOS DERIVADOS DE FURO[3,2-D]PIRIMIDINA Y SUS SALES； COMPOSICION FARMACEUTICA QUE LOS COMPRENDE； Y SU USO PARA TRATAR UNA AFECCION QUE ESTA MEDIADA POR LA ACTIVIDAD DE UNA PROTEINA QUINASA, TAL COMO CANCER, TRASTORNOS CARDIOVASCULARES, DEL SNC E INMUNES, Y ENFERMEDADES RELACIONADAS CON LA INMUNODEFICIENCIA ADQUIRIDA.
